Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04039945 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Fr1da Early Diagnosis and Care of Type 1 Diabetes

Study acronym: Fr1da
StatusRecruiting
PhaseNot specified
Started2015-02
View on ClinicalTrials.gov ↗
The Fr1da study: "Early diagnosis and care of type 1 diabetes" aims to carry out a comprehensive, population-based screening for the early diagnosis of type 1 diabetes as part of the U7 to U11 preventive medical check-up for children or between the ages of 2 and 10 years in Bavaria and to implement it in other federal states. Screening is recommended at two time points: 1st screening at the age of 3 years (U7a) and 2nd screening at the age of 7 years (U10). In addition, relatives of patients with type 1 diabetes between the ages of 1 and 21 can be screened repeatedly at intervals of 3 to 5 years for an early-stage of type 1 diabetes.

Amendment record

Amended 4 times since 2019-07-30; most recent filed 2024-12-12. Every amendment is listed below.

Dates here are the day the sponsor filed the amendment, not the day ClinicalTrials.gov published it. Version history last read from ClinicalTrials.gov on 2026-08-30.

2024-12-12
Amendment Study Identification, Study Status, Study Description, Study Design, Eligibility v4
2023-09-21
Amendment Study Status v3
2022-03-15
Amendment Study Status v2
2021-02-08
Amendment Study Status v1
2019-07-30
Original filing
Trial Details
NCT Number NCT04039945
Lead Sponsor Helmholtz Zentrum München
Conditions Type 1 Diabetes Mellitus
Enrollment 285,000 participants
Start Date 2015-02
Primary Completion 2028-12 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2024-12-17